SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/4A461F46A4776CAD6BD330007281F5A1EEEA0903C3277F341DB62E16CC5F46BEA272239DCFAAEAEFC6F9AB3FB9B35B93>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/4A461F46A4776CAD6BD330007281F5A1EEEA0903C3277F341DB62E16CC5F46BEA272239DCFAAEAEFC6F9AB3FB9B35B93
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/4A461F46A4776CAD6BD330007281F5A1EEEA0903C3277F341DB62E16CC5F46BEA272239DCFAAEAEFC6F9AB3FB9B35B93
http://www.w3.org/2000/01/rdf-schema#comment
"Data indicate that palmitoyl-carnitine (PC) increases the type 2 ryanodine receptor (RyR2) oxidation and reduces the ATP/ADP translocase (ANT) activity."
xsd:string
http://purl.uniprot.org/uniprot/#_F9BF4DE015CACBD1E890E3BCC8F5D952F59EB2625EE481E93295F3A223EE55744F74CA70D811F4C4027D026538BEB73A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/4A461F46A4776CAD6BD330007281F5A1EEEA0903C3277F341DB62E16CC5F46BEA272239DCFAAEAEFC6F9AB3FB9B35B93
http://purl.uniprot.org/uniprot/E9Q401
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4A461F46A4776CAD6BD330007281F5A1EEEA0903C3277F341DB62E16CC5F46BEA272239DCFAAEAEFC6F9AB3FB9B35B93
http://purl.uniprot.org/uniprot/#_E9Q401-mappedCitation-25619687
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4A461F46A4776CAD6BD330007281F5A1EEEA0903C3277F341DB62E16CC5F46BEA272239DCFAAEAEFC6F9AB3FB9B35B93